pdufa date for tirzepatide FDA Grants a New Indication Obesity Management Drugs to Watch 2025: 11

A thorough consultation and health assessment before starting treatment is essential

We've noticed that Henry often provides first-month discounts around most federal holidays in the U.S., which gives you the opportunity to save a bit of money when trying out its services

Semaglutide GLP-1 Weight Loss Tracker Track your Semaglutide injections, monitor side effects and visualize estimated medication levels across your GLP-1 cycle

Constipation, indigestion, and loss of appetite are also common side effects

Hormone levels that may have been low for months or years suddenly begin to change

Generally, the eligibility criteria include having a body mass index (BMI) that categorizes the individual as overweight or obese, typically a BMI of 30 or higher, or a BMI of 27 or higher if accompanied by weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidemia